Ashland (ASH) Stock
Publicly traded company. Here's the price, business snapshot, and what's worth knowing about Ashland in August 2026.
Ashland Inc. is a global additives and specialty ingredients company. The Company serves customers in a range of consumer and industrial markets, including architectural coatings, construction, energy, food and beverage, personal care and pharmaceuticals. The Company's segments include Life Sciences, Personal Care, Specialty Additives, and Intermediates. The Life Sciences segment consists of pharmaceuticals, nutrition, agricultural chemicals, diagnostic films and fine chemicals. The Personal Care segment includes functionals, microbial protectants (preservatives), skin care, sun care, oral care, hair care and household solutions. The Specialty Additives segment consists of rheology and performance-enhancing additives serving the architectural coatings, construction, energy, automotive and various industrial markets. The Intermediates segment consists of the production of 1,4 butanediol (BDO) and related derivatives, including n-methyl pyrrolidone.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Ashland's stock with a target price of $69.67, indicating strong growth potential.
Financial Health
Ashland Inc is performing well with strong revenue and cash flow, indicating solid financial stability.
Dividend
Ashland Inc's dividend yield of 2.99% offers a decent return for dividend-seeking investors. If you invested $1000 you would be paid $29.90 a year in dividends (based on the last 12 months).
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Discover More Opportunities
AIR PRODUCTS & CHEMICALS INC
Air Products and Chemicals is a global supplier of industrial gases, specialty gases, and related equipment, services, and technologies.
Albemarle
Produces and markets specialty chemicals worldwide.
Axalta
Axalta Coating Systems is a global provider of liquid and powder coatings for the automotive, commercial transportation, and industrial markets.
Baskets Featuring ASH
Personal Care Safety: Could Talc Verdict Boost Stocks?
A record $1.5 billion verdict against Johnson & Johnson in a talc cancer case highlights the immense legal and financial risks associated with certain consumer product ingredients. This creates a compelling investment opportunity in companies that provide safer, alternative materials and advanced testing services for the personal care industry.
Published: 24 December 2025
Explore BasketWhy invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.